Movember Discovery Grants

Access to the Online Application: https://pccgrants.smartsimple.ca
Registration Deadline: February 15, 2017
Full Application Deadline: April 3, 2017
Funding Start Date: July 1, 2017smaller.jpg



Prostate Cancer Canada (PCC) is offering a limited number of Discovery Grants. While supporting novel research that aims to open up new lines of investigation, the goal is to support new and innovative studies in prostate cancer research.
The Discovery Grant program will:
  • allow both junior and more established investigators to pursue new avenues of exploration
  • allow applications from all areas of prostate cancer research
  • provide a budget of up to $200,000 per project that can be spent in up to two years of funding, thereby allowing some flexibility
  • fund applications that will have been evaluated by a rigorous peer-review process that assessed:
    • Innovation
    • Track record of investigator team
    • Feasibility of the proposed work
    • Potential impact on prostate cancer

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • biomedical
  • clinical
  • population health
  • health services/economics

This opportunity is proudly funded by the Movember Foundation.


Discovery Grants that are based at institutions in New Brunswick and have met both scientific meritorious and financial cut-off requirements will be co-funded by PCC and the New Brunswick Health Research Foundation.

Links to:
Online application: https://pccgrants.smartsimple.ca
Program Description
Tipsheet for applicants


 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More

Scientists identify DNA signature linked to prostate cancer severity

January 9, 2017 – TORONTO, ON – The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature.
More

Thank You to our Canadian Mo Bros and Sistas!

TORONTO, December 1, 2016 - Prostate Cancer Canada congratulates the more than 500,000 Mo Bros and Mo Sistas worldwide who participated in this year's Movember campaign.
More


Click here for news archive